Page last updated: 2024-08-17

carbostyril and Temporomandibular Joint Disorders

carbostyril has been researched along with Temporomandibular Joint Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hutami, IR; Izawa, T; Tanaka, E1
Hutami, IR; Iwasa, A; Izawa, T; Mino-Oka, A; Mori, H; Shinohara, T; Tanaka, E1

Reviews

1 review(s) available for carbostyril and Temporomandibular Joint Disorders

ArticleYear
Potential Role of Rebamipide in Osteoclast Differentiation and Mandibular Condylar Cartilage Homeostasis.
    Current rheumatology reviews, 2018, Apr-20, Volume: 14, Issue:1

    Topics: Alanine; Animals; Antioxidants; Cartilage, Articular; Cell Differentiation; Homeostasis; Humans; Mandibular Condyle; Osteoarthritis; Osteoclasts; Quinolones; Temporomandibular Joint; Temporomandibular Joint Disorders

2018

Other Studies

1 other study(ies) available for carbostyril and Temporomandibular Joint Disorders

ArticleYear
Rebamipide Attenuates Mandibular Condylar Degeneration in a Murine Model of TMJ-OA by Mediating a Chondroprotective Effect and by Downregulating RANKL-Mediated Osteoclastogenesis.
    PloS one, 2016, Volume: 11, Issue:4

    Topics: Administration, Oral; Alanine; Animals; Anti-Inflammatory Agents; Apoptosis; Arthritis, Experimental; Cartilage, Articular; Chondrocytes; Drug Administration Schedule; Extracellular Matrix; Gene Expression Regulation; Mandibular Condyle; Matrix Metalloproteinase 13; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; NFATC Transcription Factors; Nitric Oxide Synthase Type II; Osteoarthritis; Osteoclasts; Osteogenesis; Quinolones; RANK Ligand; Signal Transduction; Temporomandibular Joint; Temporomandibular Joint Disorders

2016